Correspondence 0001193125-22-309510 from HTG MOLECULAR DIAGNOSTICS, INC (HTGMQ) (CIK 0001169987)
HTG MOLECULAR DIAGNOSTICS, INC (HTGMQ) (CIK 0001169987)
Date: Dec. 21, 2022 · CIK: 0001169987 · Accession: 0001193125-22-309510
AI Filing Summary & Sentiment
File numbers found in text: 333-268681
Show Raw Text
CORRESP 1 filename1.htm CORRESP December 21, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance Washington, DC 20549 Re: HTG Molecular Diagnostics, Inc. Registration Statement on Form S-1 (Registration No. 333-268681) - Concurrence in Acceleration Request Ladies and Gentlemen: H.C. Wainwright & Co., LLC (“Wainwright”), solely acting as placement agent on a best-efforts basis in an offering pursuant to the registration statement on Form S-1 (333-268681) (the “Registration Statement”), hereby concurs in the request by HTG Molecular Diagnostics, Inc. (the “Company”) that the effective date of the above-referenced registration statement be accelerated to 1:00 P.M. (Eastern Time), or as soon as practicable thereafter, on December 21, 2022, or at such other time as the Company or its outside counsel, Cooley LLP, request by telephone that the Registration Statement be declared effective, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement. Very truly yours, H.C. WAINWRIGHT & CO., LLC By: /s/ Edward D. Silvera Name: Edward D. Silvera Title: Chief Operating Officer 430 Park Avenue | New York, NY 10022 | 212.356.0500 | www.hcwco.com Member: FINRA/SIPC